EUDA Health Holdings Limited (EUDA)

Market Cap	33.18M -76.0%
Revenue (ttm)	6.82M +70.0%
Net Income	-2.77M
EPS	-1.48
Shares Out	2.52M
PE Ratio	n/a
Forward PE	8.24
Dividend	n/a
Ex-Dividend Date	n/a

Volume	21,893
Open	13.03
Previous Close	13.17
Day's Range	13.00 - 14.25
52-Week Range	5.26 - 86.00
Beta	0.56
Analysts	Strong Buy
Price Target	55.00 (+316.98%)
Earnings Date	Dec 19, 2023

About EUDA

EUDA Health Holdings Limited engages in the provision of non-invasive healthcare services primarily in Singapore, Malaysia, and China. It offers bioenergy capsule, stem cell therapy, and CRISPR gene editing treatment services; and supplements. The company also provides property management services. The company is headquartered in Singapore.

• Industry: Real Estate Services
• Sector: Real Estate
• Founded: 2021
• Employees: 117
• Stock Exchange: NASDAQ
• Ticker Symbol: EUDA
• Website: https://eudahealth.com

Financial Performance

In 2025, EUDA Health Holdings's revenue was $6.82 million, an increase of 70.04% compared to the previous year's $4.01 million. Losses were -$2.77 million, -81.94% less than in 2024.

Analyst Summary

According to one analyst, the rating for EUDA stock is "Strong Buy" and the 12-month stock price target is $55.0.

Price Target

$55.0

(316.98% upside)

Analyst Consensus: Strong Buy